Zeta Myeloperoxidase Antibody. Zeta’s recombinant mouse antibody recognizes Myeloperoxidase (MPO), an important enzyme used by granulocytes during phagocytic lysis of foreign particles engulfed. In normal tissues and in a variety of myeloproliferative disorders myeloid cells of both neutrophilic and eosinophilic types, at all stages of maturation, exhibit strong cytoplasmic reactivity for Myeloperoxidase (MPO). Erythroid precursors, megakaryocytes, lymphoid cells, mast cells, and plasma cells are nonreactive to Myeloperoxidase (MPO). Myeloperoxidase (MPO) is not observed in the neoplastic cells of a wide variety of epithelial tumors and sarcomas. Myeloperoxidase (MPO) is useful in differentiating between myeloid and lymphoid leukemias.
Zeta Corporation is a leader in recombinant monoclonal IVD antibodies for immunohistochemistry (IHC) offering 400+ tumor and tissue specific relevant products developed by a pathologist for pathologists. Visit Precision Recombinant Antibodies – IVD Antibodies – About Zeta Corporation (zeta-corp.com) to learn more about Zeta Corporation.